泓博医药：2025年前三季度拟派现1375.40万元
Pharma Resources (Shanghai) Pharma Resources (Shanghai) (SZ:301230) Xin Lang Cai Jing·2025-10-29 08:03

Core Points - The company reported a net profit of 34.7496 million yuan for the first three quarters of 2025 [1] - The total share capital, after deducting repurchased shares, is 138 million shares [1] - The company plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares held, amounting to a total cash dividend of 13.754 million yuan (including tax) [1] - This dividend proposal is subject to approval at the third extraordinary general meeting of shareholders in 2025 [1]